Cherin Smith

Cherin Smith, PMP, currently serves as the Executive Vice President and Head of Clinical Operations at Entera Bio Ltd., leading clinical operations for compounds in various stages of development. Prior roles include Senior Director of Clinical Operations for Rare Disease at Acadia Pharmaceuticals Inc., where leadership was provided for pivotal Phase 3 and real-world evidence studies, and Senior Director at Sumitomo Pharma America, Inc. Experience also includes positions at ICON plc, PRA Health Sciences, Chiltern, INC Research, and MDS Pharma Services, with progressive responsibilities in project management and clinical operations. Cherin Smith holds a Bachelor of Science degree in Psychobiology from UCLA.